Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemot...
Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Current guidelines recommend the combination of a neurokinin-1 (NK
) receptor antagonist (RA) and a 5-hydroxytryptamine-3 (5-HT
) RA, together with corticosteroids, in order to prevent chemotherapy-induced nausea and vomiting with anthracycline-cyclophosphamide and highly emetogenic chemotherapy, and it is to be considered with moderately eme...
Alternative Titles
Full title
Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1656046556
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1656046556
Other Identifiers
ISSN
1479-6694,1744-8301
E-ISSN
1744-8301
DOI
10.2217/fon.14.260
